NCT
HOME CURRENT ARCHIVE COVID-19
HOME CURRENT ARCHIVE PUBLISH INSTRUCTIONS
FOR AUTHORS COVID-19 LOG IN / REGISTER HISTORY ABOUT US DIRECTORY CONTACT
E-health strategy to improve the diagnosis of COPD and asthma in México's Primary Care

Vázquez-García, Juan Carlos1; Benítez-Pérez, Rosaura Esperanza1; Sánchez-Gallén, Elisa1; Fernández-Vega, Margarita1; Hernández-Zenteno, Rafael de Jesús1; Salas-Hernández, Jorge1; Pérez-Padilla, Rogelio1; Reyes-Herrera, Adela2; Ruiz-Ascencio, Diana2; Camargo-Ángeles, Robert2





2021, Number 1

2021; 80 (1)






ABSTRACT

KEYWORDS

Telemedicine, pulmonary disease chronic obstructive, asma, primary health care.

REFERENCES

  1. Perez-Padilla R. Hidden respiratory disease-associated deaths. Int J Tuberc Lung Dis. 2008;12(4):458-464.

  2. WHO. [Fecha de consulta: 30 de octubre de 2020]. Accesible en: https://www.who.int/en/news-room/fact-sheets/detail/noncommunicable-diseases.

  3. WHO. [Fecha de consulta: 27 de octubre de 2020]. Accesible en: https://www.who.int/es/news-room/fact-sheets/detail/asthma.

  4. WHO. [Fecha de consulta: 27 de octubre de 2020]. Accesible en: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).

  5. WHO. [Fecha de consulta: 27 de octubre de 2020]. Accesible en: https://www.who.int/es/news-room/fact-sheets/detail/the-top-10-causes-of-death.

  6. Cubos de mortalidad/DGIS/SS/2020. [Fecha de consulta: 27 de octubre de 2020]. Accesible en: http://www.dgis.salud.gob.mx/contenidos/basesdedatos/bdc_defunciones_gobmx.html.

  7. Menezes AMB, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, et al.; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875-1881. https://doi.org/10.1016/s0140-6736(05)67632-5.

  8. Piedras MMP, Huerta LJ. Mortalidad por asma. Alerg Asma Inmunol Pediatr. 2011;20(3):107-119.

  9. Del-Rio-Navarro B, Del Rio-Chivardi JM, Berber A, Sienra-Monge JJL, Rosas-Vargas MA, Baeza-Bacab M. Asthma prevalence in children living in north Mexico City and a comparison with other Latin American cities and world regions. Allergy Asthma Proc. 2006;27(4):334-340. https://doi.org/10.2500/aap.2006.27.2880.

  10. Del-Rio-Navarro B, Berber A, Blandón-Vijil V, Ramírez-Aguilar M, Romieu I, Ramírez-Chanona N, et al. Identification of asthma risk factors in Mexico City in an International Study of Asthma and Allergy in Childhood survey. Allergy Asthma Proc. 2006;27(4):325-333. https://doi.org/10.2500/aap.2006.27.2874

  11. Morfín-Maciel B, Barragán-Meijueiro M de L, Nava-Ocampo AA. Individual and family household smoking habits as risk factors for wheezing among adolescents. Prev Med. 2006;43(2):98-100. https://doi.org/10.1016/j.ypmed.2006.04.002.

  12. Violante R, del Río Navarro BE, Berber A, Ramírez Chanona N, Baeza Bacab M, Sienra Monge JJ. Obesity risk factors in thE ISAAC (International Study of Asthma and Allergies in Childhood) in Mexico City. Rev Alerg Mex. 2005;52(4):141-145.

  13. Del Río-Navarro BE, Hernández-Román MP, Espinola Reyna G, Berber A, Escalante-Dominguez AJ, González-Reyes M, et al. A comparative study of bronchodilator reversibility with albuterol, between asthma symptomatic and asymptomatic children according to ISAAC questionnaire in Mexico City. Allergol Immunopathol (Madr). 2004;32(6):334-339. https://doi.org/10.1016/s0301-0546(04)79265-4.

  14. Barraza-Villarreal A, Sanín-Aguirre LH, Téllez-Rojo MM, Lacasaña-Navarro M, Romieu I. Prevalence of asthma and other allergic diseases in school children from Juarez City, Chihuahua. Salud Publica Mex. 2001;43(5):433-443.

  15. Mendoza-Mendoza A, Romero-Cancio JA, Pena-Rios HD, Vargas MH. Prevalence of asthma in schoolchildren from the Mexican City Hermosillo. Gac Med Mex. 2001;137(5):397-401.

  16. Rojas Molina N, Legorreta Soberanis J, Olvera Guerra F. Prevalence and asthma risk factors in municipalities of the State of Guerrero, Mexico. Rev Alerg Mex. 2001;48(4):115-118.

  17. Tatto-Cano MI, Sanín-Aguirre LH, González V, Ruiz-Velasco S, Romieu I. Prevalence of asthma, rhinitis and eczema in school children in the City of Cuernavaca, Mexico. Salud Publica Mex. 1997;39(6):497-506.

  18. García-Sancho C, Fernández-Plata R, Martínez-Briseño D, Franco-Marina F, Pérez-Padilla JR. Prevalencia y riesgos asociados con pacientes adultos con asma de 40 años o más de la Ciudad de México: estudio de base poblacional. Salud Publica Mex. 2012;54(4):425-432. Accesible en: https://saludpublica.mx/index.php/spm/article/view/7156.

  19. Guía Mexicana de Asma. Neumol Cir Torax. 2017;76(suppl):s1-s136.

  20. Reynales-Shigematsu LM. Costos de atención médica de las enfermedades atribuibles al consumo de tabaco en América: revisión de la literatura. Salud Publica Mex. 2006;48(suppl I):S190-S200.

  21. Fernández-Plata R, Martínez-Briseño D, García-Sancho F, Cano-Jiménez D, Ramírez-Venegas A, Sansores-Martínez R, et al. Métodos para la estimación de costos en salud de la EPOC: resultados basales. Neumol Cir Torax. 2016;75(1):4-11.

  22. Tálamo C, de Oca MM, Halbert R, Pérez-Padilla R, Jardim JRB, Muiño A, et al.; PLATINO team. Diagnostic labeling of COPD in five Latin American cities. Chest. 2007;131(1):60-67. https://doi.org/10.1378/chest.06-1149.

  23. Guía de Práctica Clínica Mexicana para el diagnóstico y tratamiento de la Enfermedad Pulmonar Obstructiva Crónica. Neumol Cir Torax. 2019;78(suppl):s20-s22.

  24. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2017 Update. Available from: http://ginasthma.org/.

  25. The Royal College of Physicians of London/BTS/BLF. Report 5 of The National Chronic Obstructive Pulmonary Disease Audit 2008: survey of COPD care within UK General Practices. 2008. [Accessed October 27, 2020]. Available at https://www.rcplondon.ac.uk/projects/outputs/national-copd-audit-2008.

  26. Levy ML, Quanjer PH, Booker R, Cooper BG, Holmers S, Small I; General Practice Airways Group. Diagnostic spirometry in primary care. Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. Prim Care Respir J. 2009;18(3):130-147. https://doi.org/10.4104/pcrj.2009.00054.

  27. Coates AL, Graham BL, McFadden RG, McParland C, Moosa D, Provencher S, et al. Spirometry in primary care. Can Respir J. 2013;20(1):13-21. https://doi.org/10.1155/2013/615281.

  28. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Care. 2000;45(5):513-530.

  29. Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971-985. https://doi.org/10.1378/chest.14-2535.

  30. Martinez CH, Mannino DM, Jaimes FA, Curtis JL, Han MK, Hansel NN, et al. Undiagnosed obstructive lung disease in the United States. Associated Factors and long-term mortality. Ann Am Thoracic Soc. 2015;12(12):1788-1795. doi: 10.1513/AnnalsATS.201506-388OC.

  31. Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673-678. https://doi.org/10.1503/cmaj.091784.

  32. Casas HA, Montes OM, López VM, Aguirre C, Schiavi E, Jardim JR; PUMA Team. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: The PUMA Study. PLoS One. 2016;11(4):e0152266. https://doi.org/10.1371/journal.pone.0152266.

  33. Laniado-Laborin R, Rendón A, Bauerle O. Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population. Int J Tuberc Lung Dis. 2011;15(6):818-823. https://doi.org/10.5588/ijtld.10.0546.

  34. Sansores RH, Velázquez-Uncal M, Pérez-Bautista O, Villalba-Caloca J, Farfán-Valencia R, Ramírez-Venegas A. Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers. Int J Chron Obstruct Pulmon Dis. 2015;10:2357-2363. https://doi.org/10.2147/copd.s91742.

  35. Guirguis-Blake JM, Senger CA, Webber EM, Mularski R, Whitlock EP. Screening for chronic obstructive pulmonary disease: A systematic evidence review for the U.S. preventive services task force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. (Evidence Syntheses, No. 130.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK361185/.

  36. Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317(3):269-279. https://doi.org/10.1001/jama.2016.19627.

  37. Looijmans-Van den Akker I, van Luijn K, Verheij T. Overdiagnosis of asthma in children in primary care: a retrospective analysis. Br J Gen Pract. 2016;66(644):e152-e157. https://doi.org/10.3399/bjgp16x683965.

  38. José BP, Camargos PA, Cruz Filho AA, Correa R de A. Diagnostic accuracy of respiratory diseases in primary health units. Rev Assoc Med Bras (1992). 2014;60(6):599-612. https://doi.org/10.1590/1806-9282.60.06.021.

  39. MacNeil J, Loves RH, Aaron SD. Addressing the misdiagnosis of asthma in adults: where does it go wrong? Expert Rev Respir Med. 2016;10(11):1187-1198. https://doi.org/10.1080/17476348.2016.1242415.

  40. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: Major change for the better. Thorax. 2006;61(8):663-670. https://doi.org/10.1136/thx.2005.055699.

  41. Tuomisto L, Erhola M, Kaila M, Brander PE, Puolijoki H, Kauppinen R, et al. Asthma Programme in Finland: high consensus between general practitioners and pulmonologists on the contents of an asthma referral letter. Prim Care Respir J. 2004;13(4):205-210. https://doi.org/10.1016/j.pcrj.2004.04.001.

  42. Tuomisto LE, Erhola M, Kaila M, Brander PE, Kauppinen R, Puolijoki H, et al. The Finnish national asthma programme: Communication in asthma care-quality assessment of asthma referral letters. J Eval Clin Pract. 2007;13(1):50-54. https://doi.org/10.1111/j.1365-2753.2006.00645.x.

  43. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338. https://doi.org/10.1183/09031936.05.00034805.

  44. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Guideline 2019. https://doi.org/10.1164/rccm.201908-1590ST.

  45. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968. https://doi.org/10.1183/09031936.05.00035205.

  46. Pérez-Padilla R, Vázquez-García JC, Márquez MN, Menezes AMB; PLATINO Group. Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care. 2008;53(8):1019-1026.

  47. Enright P, Schermer T. Don't pay for poor quality spirometry tests. Prim Care Respir J. 2013;22(1):15-16. https://doi.org/10.4104/pcrj.2013.00023.

  48. Perez-Padilla R, Torre Bouscoulet L, Vázquez García JC. Implementing a spirometry program. Int J Tuberc Lung Dis. 2016;20(9):1142. https://doi.org/10.5588/ijtld.16.0512.

  49. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116(2):416-423. https://doi.org/10.1378/chest.116.2.416.

  50. Enright P, Vollmer WM, Lamprecht B, Jensen R, Jithoo A, Tan W, et al. Quality of spirometry tests performed by 9893 adults in 14 countries: the BOLD Study. Respir Med. 2011;105(10):1507-1515. https://doi.org/10.1016/j.rmed.2011.04.008.

  51. Enright PL. Should we keep pushing for a spirometer in every doctor's office? Respir Care. 2012;57(1):146-153. https://doi.org/10.4187/respcare.01504.

  52. Cawley MJ, Moon J, Reinhold J, Willey VJ, Warning li WJ. Spirometry: tool for pharmacy practitioners to expand direct patient care services. J Am Pharm Assoc (2003). 2013;53(3):307-315. https://doi.org/10.1331/japha.2013.12134.

  53. Tuomisto L, Jarvinen V, Laitinen J, Erhola M, Kaila M, Brander P. Asthma Programme in Finland: the quality of primary care spirometry is good. Prim Care Respir J. 2008;17(4):226-231. https://doi.org/10.3132/pcrj.2008.00053.

  54. Licskai CJ, Sands TW, Paolatto L, Nicoletti I, Ferrone M. Spirometry in primary care: An analysis of spirometry test quality in a regional primary care asthma program. Can Respir J. 2012;19(4):249-254. https://doi.org/10.1155/2012/653084.

  55. Johnston JC, Rempel C, Sanders C, Piggott E, Maxwell Y, Jaipersaud K, et al. Introduction of spirometry into clinical practice in Georgetown, Guyana: quality and diagnostic outcomes. Int J Tuberc Lung Dis. 2016;20(9):1270-1274. https://doi.org/10.5588/ijtld.16.0068.

  56. Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood-Baker R. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax. 2008;63(5):408-414. https://doi.org/10.1136/thx.2007.082859.

  57. Poels PJ, Schermer TR, Schellekens DP, Akkermans RP, de Vries Robbé PF, Kaplan A, et al. Impact of a spirometry expert system on general practitioners' decision making. Eur Respir J. 2008;31(1):84-92. https://doi.org/10.1183/09031936.00012007.

  58. Burgos F, Disdier C, de Santamaria EL, Galdiz B, Roger N, Rivera ML, et al. Telemedicine enhances quality of forced spirometry in primary care. Eur Respir J. 2012;39(6):1313-1318. https://doi.org/10.1183/09031936.00168010.

  59. Burgos F. Telemedicina en el laboratorio de función pulmonar. En: Casan C, García RF, Gea GJJ, editores. Fisiología y biología respiratoria. ISB 978-84-8473-572-4. España: Ergon 2007. p. 313-328.

  60. Pérez-Padilla R, Torre-Bouscoulet L, Gochicoa-Rangel L, Vázquez-García JC. 20 años de entrenamiento en espirometría en América Latina. Neumol Cir Torax. 2017;76(1):4-6.

  61. Vázquez García JC, Ortiz-Siordia R, Franco-Marina F, Salas-Hernández, Benítez-Pérez RE, Pérez-Padilla R. Impacto de un curso taller de cinco horas en la interpretación de la espirometría. Neumol Cir Torax. 2019;78(3):270-276.

  62. Sandoval-Gutiérrez JL, Monraz-Pérez S, Benítez-Pérez RE, Mireles Cabodevila E. Utilidad de la telemedicina en las enfermedades respiratorias. Neumol Cir Torax. 2020;79(1):12-16.


2021, Number 1

2021; 80 (1)